(Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a ...

World’s largest maker of electric-vehicle batteries could expand its IPO deal to as much as US$5.3 billion if several upsize options are exercised.

Charming Medical, which provides therapies and products inspired by traditional Chinese medicine, filed for an initial public offering of 1.6 million shares. The company said in a filing with the ...

Pony AI Inc has confidentially filed for Hong Kong IPO to raise capital for expansion. Its stock surged and caught fire for ...

Chinese mining company Zijin Mining plans to spin off its gold business and list it on the Hong Kong stock exchange, with ...

This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.

The world’s biggest IPO this year excludes U.S. onshore investors. The decision reduces geopolitical risks that loom over ...

Hong Kong has long been a place where money moves fast and nothing stays idle. From its early days as a British trading ...

These agreements aim to support both companies in expanding their presence into promising Middle Eastern markets ...

US stock futures held steady after a strong trading session on Wall Street, where the S&P 500 erased its losses for 2025.

This week, CATL, a leading domestic lithium battery company, launched its Hong Kong IPO, heating up the lithium battery sector.

Digital banking fintech firm Chime disclosed a rise in 2024 revenue in its IPO filing on Tuesday for a long-awaited U.S.